LHF-535
Product Specifications
UNSPSC Description
LHF-535 is an antiviral agent extracted from patent WO2013123215A2, Compound 38, has EC50s of [1].
Target Antigen
Arenavirus
Type
Reference compound
Related Pathways
Anti-infection
Applications
Neuroscience-Neuromodulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lhf-535.html
Purity
99.14
Solubility
DMSO : 150 mg/mL (ultrasonic)
Smiles
OC(C)(C)C1=CC=C(/C=C\C2=CC=C3C(N=CN3C4=CC=C(OC(C)C)C=C4)=C2)C=C1
Molecular Weight
412.52
References & Citations
[1]Dongcheng Dai, et al. Antiviral drugs for treatment of arenavirus infection. WO2013123215A2.|[2]Madu IG, et al. A potent Lassa virus antiviral targets an arenavirus virulence determinant. PLoS Pathog. 2018 Dec 21;14(12):e1007439.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-112762/LHF-535-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-112762/LHF-535-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
1450929-77-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC230221L4V 200 µL
VANGL1 (NM_001172411) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details ![Rabbit Polyclonal SETD3 Antibody [Alexa Fluor 594]](https://cdn.genprice.uk/genprice/genprice4.png)
